MedTech Innovation Development and Acceleration Scheme in Diagnostic and Digital Health – MIDAS (Dx)

Accelerating Early-Stage Innovation for Real World Translation

What is MIDAS (Dx)?

The MedTech Innovation Development and Acceleration Scheme in diagnostic and digital health (MIDAS (Dx)) is an upstream funding scheme designed to seed and de-risk high quality early-stage (TRL 2 – 3) innovation. MIDAS (Dx) supports researchers and clinicians to translate strong science into clinically relevant, market-driven projects that are positioned for downstream productization and adoption.  

Why MIDAS (Dx)?

Despite strong research and clinical insight, many promising diagnostic and digital health concepts face a gap at the earliest stages of translation—where uncertainty around feasibility, clinical utility, regulation, and adoption limits progress and investability.

MIDAS (Dx) addresses this gap by embedding industry‑oriented review, active project stewardship, and productization discipline from the outset, enabling teams to generate credible proof‑of‑concepts evidence relevant to real clinical and care settings.

Have Any Questions

For enquiries or further clarification, please contact us at MIDAS@dxdhub.sg. Kindly allow three to five working days for our response.